【ChiCTR1900026245】The role of extended antral resection on weight loss and metabolic response after sleeve gastrectomy: a retrospective cohort study
ChiCTR1900026245
结束
/
/
/
2019-09-28
/
/
obesity surgery
The role of extended antral resection on weight loss and metabolic response after sleeve gastrectomy: a retrospective cohort study
The role of extended antral resection on weight loss and metabolic response after sleeve gastrectomy: a retrospective cohort study
41900
LSG was initially designed as the first step of a two-staged bariatric procedure. However, in the following years, LSG was found as effective as other bariatric procedures and has become increasingly popular as a stand-alone bariatric procedure [1,2]. Recently, LSG is the most performed bariatric procedure worldwide [3]. The simplicity of surgical technique, preservation of the pyloric functions, none development of marginal ulcers or internal herniation, less need of trace element and vitamin supplementation are the advantages of LSG over other bariatric procedures [4-6]. However, debate continues regarding the AR or AP on effective weight loss alterations and metabolic response. Further, the distance from pylorus at which the stomach division should be started is still not standardized and has been reported varying from 2 to 8cm [7-9]. The aim of the present retrospective cohort study was to determine whether AR is superior to AP regarding weight loss and resolution of co-morbidities.
队列研究
回顾性研究
N/A
N/A
not funding
/
43;68
/
2016-01-01
2018-06-30
/
Patients with BMI > 40 were included.；
请登录查看Patients with a history of previous bariatric surgery and patients who did not attend regular follow-up visits (first, 6th and 12 month) are excluded.；
请登录查看not sponsored
41900
not sponsored的其他临床试验
土耳其安卡拉科卡埃利·德里斯培训和研究医院的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04